| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
SEATTLE—New research conducted by Arizona State University’s (ASU) Biodesign Institute and published in Science Advances (a publication of the American Association for the Advancement of Science) has reportedly revealed for the first time the application of three-dimensional optical computed tomography (3D optical CT) on the cellular imaging of live cells.
 
According to VisionGate, this study further demonstrates that the 3D optical CT approach used by VisionGate’s Cell-CT Imaging and Analysis Platform provides a significant advantage over other 3D imaging modalities that are based on conventional 2D microscopy. The company also touts that “the emergence of live-cell CT adds the fourth dimension of time.”
 
The study’s principal investigator, Prof. Deirdre Meldrum, commented that “the Cell-CT platform combined with live-cell imaging and fluorescence marker analysis will revolutionize our understanding of disease at the cellular level, where disease prediction and companion diagnostics for personalized medicine are poised to change the paradigm for improved healthcare.”
 
Moreover, VisionGate maintains that these study findings validate that the principles of the Cell-CT technology can be expanded into the realm of live-cell imaging and analysis. The technology was originally developed by VisionGate, and the company is nearing commercialization of the Cell-CT platform for the detection of early-stage lung cancer.
 
VisionGate also says that its “evolving capability to perform true three-dimensional imaging at the single-cell level holds the promise to enable better understanding of how cells function, opening the door for development of new diagnostic methods and ultimately the development of new medicines.”

Related Topics

Published In

Volume 14 - Issue 2 | February 2018

February 2018

February 2018 Issue

Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue